Stock Price Forecast

June 30, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading PRA Health Sciences Inc chart...

About the Company

PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.

Exchange

NASDAQ/NGS (GLOBAL SELECT MARKET)

Website

www.prahs.com

$3B

Total Revenue

17K

Employees

$11B

Market Capitalization

50.52

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PRAH News

PRA Health Sciences

6d ago, source: Forbes

PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data ...

ICON to Buy PRA Health in $12 Billion Cash-and-Stock Deal

3y ago, source: TheStreet.com

Drug and medical device maker ICON agrees to buy PRA Health Sciences in a cash-and-stock transaction valued at about $12 billion. Under terms of the deal, Dublin-based ICON will pay PRA Health ...

Regulatory Affairs Outsourcing Market To Reach USD 13.1 Billion By 2032 | DataHorizzon Research

23h ago, source:

The regulatory affair outsourcing market size was valued at USD 6.6 Billion in 2023 and is expected to reach a market size of ...

PRA Group Inc PRAA

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Guardion Health Sciences Inc

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences, Inc. (GILD)

9h ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Medical & Molecular Sciences

7mon ago, source: University of Delaware

Medical & Molecular Sciences is committed to providing skilled, critically-thinking practitioners equipped to be future leaders in health sciences. In this pursuit, the Department is committed to ...

Health Sciences

1y ago, source: Wilkes University

The Health Sciences Programs at Wilkes offers you a broad choice of medical and allied health professions. More than 90% of students who have strong academic and service records, complete the ...

Guardion Health Sciences, Inc.

3mon ago, source: CNN

Guardion Health Sciences, Inc. engages in the development and distribution of clinically supported dietary supplements and medical foods. The firm also offers science-based products and devices ...

Health Sciences

6y ago, source: Keene State College

Health Sciences is an interdisciplinary program grounded in the liberal arts. The major is comprised of courses in Health Promotion, Nutrition, Addictions, Physical Activity, Biology, Chemistry and ...

Guardion Health Sciences Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...